Matthias Klugmann, Ph.D. - Publications

Affiliations: 
Translational Neuroscience Facility The University of New South Wales, Australia 
Area:
gene therapy, glia, addiction, cannabinoids, brain metabolism
Website:
http://medicalsciences.med.unsw.edu.au/people/associate-professor-matthias-klugmann

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Fröhlich D, Suchowerska AK, Voss C, He R, Wolvetang E, von Jonquieres G, Simons C, Fath T, Housley GD, Klugmann M. Expression Pattern of the Aspartyl-tRNA Synthetase DARS in the Human Brain. Frontiers in Molecular Neuroscience. 11: 81. PMID 29615866 DOI: 10.3389/Fnmol.2018.00081  0.382
2017 Datko MC, Hu JH, Williams M, Reyes CM, Lominac KD, von Jonquieres G, Klugmann M, Worley PF, Szumlinski KK. Behavioral and Neurochemical Phenotyping of Mice Incapable of Homer1a Induction. Frontiers in Behavioral Neuroscience. 11: 208. PMID 29163080 DOI: 10.3389/Fnbeh.2017.00208  0.336
2017 von Jonquieres G, Spencer ZHT, Rowlands BD, Klugmann CB, Bongers A, Harasta AE, Parley KE, Cederholm J, Teahan O, Pickford R, Delerue F, Ittner LM, Fröhlich D, McLean CA, Don AS, ... ... Klugmann M, et al. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy. Acta Neuropathologica. PMID 29116375 DOI: 10.1007/S00401-017-1784-9  0.385
2017 Bi M, Gladbach A, van Eersel J, Ittner A, Przybyla M, van Hummel A, Chua SW, Hoven JV, Lee WS, Müller J, Parmar J, Jonquieres GV, Stefen H, Guccione E, Fath T, ... ... Klugmann M, et al. Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nature Communications. 8: 473. PMID 28883427 DOI: 10.1038/S41467-017-00618-0  0.311
2017 Bassil F, Guerin PA, Dutheil N, Li Q, Klugmann M, Meissner WG, Bezard E, Fernagut PO. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28556404 DOI: 10.1002/Mds.27041  0.307
2017 Georgiou E, Sidiropoulou K, Richter J, Papaneophytou C, Sargiannidou I, Kagiava A, von Jonquieres G, Christodoulou C, Klugmann M, Kleopa KA. Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model. Brain : a Journal of Neurology. PMID 28100454 DOI: 10.1093/Brain/Aww351  0.422
2016 Fröhlich D, Suchowerska AK, Spencer ZH, von Jonquieres G, Klugmann CB, Bongers A, Delerue F, Stefen H, Ittner LM, Fath T, Housley GD, Klugmann M. In vivocharacterization of the aspartyl-tRNA synthetase DARS: Homing in on the leukodystrophy HBSL. Neurobiology of Disease. PMID 27816769 DOI: 10.1016/J.Nbd.2016.10.008  0.303
2016 von Jonquieres G, Fröhlich D, Klugmann CB, Wen X, Harasta AE, Ramkumar R, Spencer ZH, Housley GD, Klugmann M. Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes. Frontiers in Molecular Neuroscience. 9: 13. PMID 26941604 DOI: 10.3389/Fnmol.2016.00013  0.443
2015 Guggenhuber S, Alpar A, Chen R, Schmitz N, Wickert M, Mattheus T, Harasta AE, Purrio M, Kaiser N, Elphick MR, Monory K, Kilb W, Luhmann HJ, Harkany T, Lutz B, ... Klugmann M, et al. Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus. Brain Structure & Function. PMID 25772509 DOI: 10.1007/S00429-015-1027-6  0.357
2015 Harasta AE, Power JM, von Jonquieres G, Karl T, Drucker DJ, Housley GD, Schneider M, Klugmann M. Septal Glucagon-Like Peptide 1 Receptor Expression Determines Suppression of Cocaine-Induced Behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1969-78. PMID 25669605 DOI: 10.1038/Npp.2015.47  0.308
2014 Lin EJ, Symes CW, Townsend-Nicholson A, Klugmann M, Klugmann CB, Lehnert K, Fong D, Young D, During MJ. An Immunological Approach to Increase the Brain's Resilience to Insults. Isrn Neuroscience. 2014: 103213. PMID 24967312 DOI: 10.1155/2014/103213  0.533
2014 von Jonquieres G, Froud KE, Klugmann CB, Wong AC, Housley GD, Klugmann M. Loss of central auditory processing in a mouse model of Canavan disease. Plos One. 9: e97374. PMID 24826990 DOI: 10.1371/Journal.Pone.0097374  0.316
2014 Pinyon JL, Tadros SF, Froud KE, Y Wong AC, Tompson IT, Crawford EN, Ko M, Morris R, Klugmann M, Housley GD. Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear. Science Translational Medicine. 6: 233ra54. PMID 24760189 DOI: 10.1126/Scitranslmed.3008177  0.643
2014 Vogt-Eisele A, Krüger C, Duning K, Weber D, Spoelgen R, Pitzer C, Plaas C, Eisenhardt G, Meyer A, Vogt G, Krieger M, Handwerker E, Wennmann DO, Weide T, Skryabin BV, ... Klugmann M, et al. KIBRA (KIdney/BRAin protein) regulates learning and memory and stabilizes Protein kinase Mζ. Journal of Neurochemistry. 128: 686-700. PMID 24117625 DOI: 10.1111/Jnc.12480  0.532
2013 Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave KA, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers EM. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. Plos Biology. 11: e1001604. PMID 23874151 DOI: 10.1371/Journal.Pbio.1001604  0.775
2013 von Jonquieres G, Mersmann N, Klugmann CB, Harasta AE, Lutz B, Teahan O, Housley GD, Fröhlich D, Krämer-Albers EM, Klugmann M. Glial promoter selectivity following AAV-delivery to the immature brain. Plos One. 8: e65646. PMID 23799030 DOI: 10.1371/Journal.Pone.0065646  0.413
2013 Obara I, Goulding SP, Gould AT, Lominac KD, Hu JH, Zhang PW, von Jonquieres G, Dehoff M, Xiao B, Seeburg PH, Worley PF, Klugmann M, Szumlinski KK. Homers at the Interface between Reward and Pain. Frontiers in Psychiatry. 4: 39. PMID 23761764 DOI: 10.3389/Fpsyt.2013.00039  0.31
2013 Obara I, Goulding SP, Hu JH, Klugmann M, Worley PF, Szumlinski KK. Nerve injury-induced changes in Homer/glutamate receptor signaling contribute to the development and maintenance of neuropathic pain. Pain. 154: 1932-45. PMID 23685007 DOI: 10.1016/J.Pain.2013.03.035  0.313
2013 El-Kordi A, Kästner A, Grube S, Klugmann M, Begemann M, Sperling S, Hammerschmidt K, Hammer C, Stepniak B, Patzig J, de Monasterio-Schrader P, Strenzke N, Flügge G, Werner HB, Pawlak R, et al. A single gene defect causing claustrophobia. Translational Psychiatry. 3: e254. PMID 23632458 DOI: 10.1038/Tp.2013.28  0.62
2013 Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave K, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers E. Neuroprotective role of oligodendroglial exosomes. Plos Biology. DOI: 10.1371/Journal.Pbio.1001604.G008  0.735
2013 Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave K, Schneider A, Simons M, Klugmann M, Trotter J, Krämer-Albers E. Somatodendritic and axonal uptake of exosomes. Plos Biology. DOI: 10.1371/Journal.Pbio.1001604.G007  0.748
2013 Jonquieres G, Mersmann N, Teahan O, Klugmann CB, Harasta AE, Lutz B, Housley GD, Klugmann M. Aav-based gene therapy approaches for the treatment of canavan disease Cytotherapy. 15. DOI: 10.1016/J.Jcyt.2013.01.042  0.397
2012 Krieger M, Both M, Kranig SA, Pitzer C, Klugmann M, Vogt G, Draguhn A, Schneider A. The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Scientific Reports. 2: 697. PMID 23019518 DOI: 10.1038/Srep00697  0.565
2012 Bénard G, Massa F, Puente N, Lourenço J, Bellocchio L, Soria-Gómez E, Matias I, Delamarre A, Metna-Laurent M, Cannich A, Hebert-Chatelain E, Mulle C, Ortega-Gutiérrez S, Martín-Fontecha M, Klugmann M, et al. Mitochondrial CB₁ receptors regulate neuronal energy metabolism. Nature Neuroscience. 15: 558-64. PMID 22388959 DOI: 10.1038/Nn.3053  0.308
2011 Nagode DA, Tang AH, Karson MA, Klugmann M, Alger BE. Optogenetic release of ACh induces rhythmic bursts of perisomatic IPSCs in hippocampus. Plos One. 6: e27691. PMID 22110723 DOI: 10.1371/Journal.Pone.0027691  0.303
2011 Mersmann N, Tkachev D, Jelinek R, Röth PT, Möbius W, Ruhwedel T, Rühle S, Weber-Fahr W, Sartorius A, Klugmann M. Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease. Plos One. 6: e20336. PMID 21625469 DOI: 10.1371/Journal.Pone.0020336  0.371
2011 Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A. CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 284-92. PMID 21139572 DOI: 10.1038/Mt.2010.271  0.534
2010 Guggenhuber S, Monory K, Lutz B, Klugmann M. AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. Plos One. 5: e15707. PMID 21203567 DOI: 10.1371/Journal.Pone.0015707  0.379
2010 Rogalewski A, Dittgen T, Klugmann M, Kirsch F, Krüger C, Pitzer C, Minnerup J, Schäbitz WR, Schneider A. Semaphorin 6A improves functional recovery in conjunction with motor training after cerebral ischemia. Plos One. 5: e10737. PMID 20505770 DOI: 10.1371/Journal.Pone.0010737  0.531
2009 Pilpel N, Landeck N, Klugmann M, Seeburg PH, Schwarz MK. Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. Journal of Neuroscience Methods. 182: 55-63. PMID 19505498 DOI: 10.1016/J.Jneumeth.2009.05.020  0.326
2008 Bilbao A, Parkitna JR, Engblom D, Perreau-Lenz S, Sanchis-Segura C, Schneider M, Konopka W, Westphal M, Breen G, Desrivieres S, Klugmann M, Guindalini C, Vallada H, Laranjeira R, de Fonseca FR, et al. Loss of the Ca2+/calmodulin-dependent protein kinase type IV in dopaminoceptive neurons enhances behavioral effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America. 105: 17549-54. PMID 19001277 DOI: 10.1073/Pnas.0803959105  0.317
2008 Klugmann M, Szumlinski KK. Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies. Behavioural Pharmacology. 19: 485-500. PMID 18690104 DOI: 10.1097/Fbp.0B013E32830C369F  0.382
2008 Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D. AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 947-56. PMID 18388917 DOI: 10.1038/Mt.2008.50  0.579
2007 Schneider M, Spanagel R, Zhang SJ, Bading H, Klugmann M. Adeno-associated virus (AAV)-mediated suppression of Ca2+/calmodulin kinase IV activity in the nucleus accumbens modulates emotional behaviour in mice. Bmc Neuroscience. 8: 105. PMID 18053176 DOI: 10.1186/1471-2202-8-105  0.308
2007 Shen H, Korutla L, Champtiaux N, Toda S, LaLumiere R, Vallone J, Klugmann M, Blendy JA, Mackler SA, Kalivas PW. NAC1 regulates the recruitment of the proteasome complex into dendritic spines. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8903-13. PMID 17699672 DOI: 10.1523/Jneurosci.1571-07.2007  0.322
2006 Monory K, Massa F, Egertová M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, ... Klugmann M, et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron. 51: 455-66. PMID 16908411 DOI: 10.1016/J.Neuron.2006.07.006  0.641
2006 Allison SJ, Baldock P, Sainsbury A, Enriquez R, Lee NJ, Lin EJ, Klugmann M, Klugman M, During M, Eisman JA, Li M, Pan LC, Herzog H, Gardiner EM. Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice. The Journal of Biological Chemistry. 281: 23436-44. PMID 16785231 DOI: 10.1074/jbc.M604839200  0.428
2006 Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, Ehrengruber MU, During MJ, Kuner R. Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nature Medicine. 12: 677-81. PMID 16715092 DOI: 10.1038/Nm1406  0.522
2006 Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Molecular and Cellular Neurosciences. 31: 303-14. PMID 16257226 DOI: 10.1016/J.Mcn.2005.09.019  0.555
2006 Szumlinski KK, Abernathy KE, Oleson EB, Klugmann M, Lominac KD, He DY, Ron D, During M, Kalivas PW. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 768-77. PMID 16160706 DOI: 10.1038/Sj.Npp.1300890  0.499
2006 Tappe A, Klugmann M, Luo C, Hirlinger D, Agarwal N, Benrath J, Ehrengruber M, During M. 353 SYNAPTIC SCAFFOLDING PROTEIN HOMER1A PROTECTS AGAINST INFLAMMATORY PAIN European Journal of Pain. 10: S94a-S94. DOI: 10.1016/S1090-3801(06)60356-X  0.486
2005 Lominac KD, Oleson EB, Pava M, Klugmann M, Schwarz MK, Seeburg PH, During MJ, Worley PF, Kalivas PW, Szumlinski KK. Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 11586-94. PMID 16354916 DOI: 10.1523/Jneurosci.3764-05.2005  0.55
2005 Szumlinski KK, Lominac KD, Oleson EB, Walker JK, Mason A, Dehoff MH, Klugmann M, Klugman M, Cagle S, Welt K, During M, Worley PF, Middaugh LD, Kalivas PW. Homer2 is necessary for EtOH-induced neuroplasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7054-61. PMID 16049182 DOI: 10.1523/Jneurosci.1529-05.2005  0.51
2005 Klugmann M, Leichtlein CB, Symes CW, Serikawa T, Young D, During MJ. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 745-53. PMID 15851013 DOI: 10.1016/J.Ymthe.2005.01.006  0.591
2005 Klugmann M, Symes CW, Leichtlein CB, Klaussner BK, Dunning J, Fong D, Young D, During MJ. AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Molecular and Cellular Neurosciences. 28: 347-60. PMID 15691715 DOI: 10.1016/J.Mcn.2004.10.002  0.521
2004 Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, Rohrer J, Griffin W, Toda S, Champtiaux NP, Berry T, Tu JC, Shealy SE, During MJ, Middaugh LD, et al. Homer proteins regulate sensitivity to cocaine. Neuron. 43: 401-13. PMID 15294147 DOI: 10.1016/J.Neuron.2004.07.019  0.506
2003 Klugmann M, Symes CW, Klaussner BK, Leichtlein CB, Serikawa T, Young D, During MJ. Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport. 14: 1837-40. PMID 14534431 DOI: 10.1097/00001756-200310060-00016  0.548
2003 During MJ, Cao L, Zuzga DS, Francis JS, Fitzsimons HL, Jiao X, Bland RJ, Klugmann M, Banks WA, Drucker DJ, Haile CN. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nature Medicine. 9: 1173-9. PMID 12925848 DOI: 10.1038/Nm919  0.587
2003 Al-Saktawi K, McLaughlin M, Klugmann M, Schneider A, Barrie JA, McCulloch MC, Montague P, Kirkham D, Nave KA, Griffiths IR. Genetic background determines phenotypic severity of the Plp rumpshaker mutation. Journal of Neuroscience Research. 72: 12-24. PMID 12645075 DOI: 10.1002/Jnr.10561  0.667
2003 During MJ, Young D, Baer K, Lawlor P, Klugmann M. Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods in Molecular Medicine. 76: 221-36. PMID 12526166 DOI: 10.1385/1-59259-304-6:221  0.496
2002 Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain : a Journal of Neurology. 125: 551-61. PMID 11872612 DOI: 10.1093/Brain/Awf043  0.578
2002 Yool D, Klugmann M, Barrie JA, McCulloch MC, Nave KA, Griffiths IR. Observations on the structure of myelin lacking the major proteolipid protein. Neuropathology and Applied Neurobiology. 28: 75-8. PMID 11849566 DOI: 10.1046/J.0305-1846.2001.00370.X  0.536
2001 Werner H, Dimou L, Klugmann M, Pfeiffer S, Nave KA. Multiple splice isoforms of proteolipid M6B in neurons and oligodendrocytes. Molecular and Cellular Neurosciences. 18: 593-605. PMID 11749036 DOI: 10.1006/Mcne.2001.1044  0.643
2001 Yool DA, Klugmann M, McLaughlin M, Vouyiouklis DA, Dimou L, Barrie JA, McCulloch MC, Nave KA, Griffiths IR. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons. Journal of Neuroscience Research. 63: 151-64. PMID 11169625 DOI: 10.1002/1097-4547(20010115)63:2<151::Aid-Jnr1007>3.0.Co;2-Y  0.587
2000 Klein L, Klugmann M, Nave KA, Tuohy VK, Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nature Medicine. 6: 56-61. PMID 10613824 DOI: 10.1038/71540  0.521
1999 Anderson TJ, Klugmann M, Thomson CE, Schneider A, Readhead C, Nave KA, Griffiths IR. Distinct Phenotypes Associated with Increasing Dosage of the PLP Gene: Implications for CMT1A Due to PMP22 Gene Duplication. Annals of the New York Academy of Sciences. 883: 234-246. PMID 29086937 DOI: 10.1111/j.1749-6632.1999.tb08585.x  0.514
1999 Dimou L, Klugmann M, Werner H, Jung M, Griffiths IR, Nave KA. Dysmyelination in mice and the proteolipid protein gene family. Advances in Experimental Medicine and Biology. 468: 261-71. PMID 10635035 DOI: 10.1007/978-1-4615-4685-6_21  0.669
1999 Anderson TJ, Klugmann M, Thomson CE, Schneider A, Readhead C, Nave KA, Griffiths IR. Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication. Annals of the New York Academy of Sciences. 883: 234-46. PMID 10586248  0.514
1999 Montague P, Kirkham D, McCallion AS, Davies RW, Kennedy PG, Klugmann M, Nave K, Griffiths IR. Reduced levels of a specific myelin-associated oligodendrocytic basic protein isoform in shiverer myelin. Developmental Neuroscience. 21: 36-42. PMID 10077700 DOI: 10.1159/000017364  0.585
1998 Werner H, Jung M, Klugmann M, Sereda M, Griffiths IR, Nave KA. Mouse models of myelin diseases. Brain Pathology (Zurich, Switzerland). 8: 771-93. PMID 9804383 DOI: 10.1111/J.1750-3639.1998.Tb00200.X  0.745
1998 Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA. Current concepts of PLP and its role in the nervous system. Microscopy Research and Technique. 41: 344-58. PMID 9672418 DOI: 10.1002/(Sici)1097-0029(19980601)41:5<344::Aid-Jemt2>3.0.Co;2-Q  0.589
1998 Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (New York, N.Y.). 280: 1610-3. PMID 9616125 DOI: 10.1126/Science.280.5369.1610  0.681
1998 Anderson TJ, Schneider A, Barrie JA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. The Journal of Comparative Neurology. 394: 506-19. PMID 9590558 DOI: 10.1002/(Sici)1096-9861(19980518)394:4<506::Aid-Cne8>3.0.Co;2-5  0.707
1998 Schwab MH, Druffel-Augustin S, Gass P, Jung M, Klugmann M, Bartholomae A, Rossner MJ, Nave KA. Neuronal basic helix-loop-helix proteins (NEX, neuroD, NDRF): spatiotemporal expression and targeted disruption of the NEX gene in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1408-18. PMID 9454850 DOI: 10.1523/Jneurosci.18-04-01408.1998  0.669
1997 Klugmann M, Schwab MH, Pühlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA. Assembly of CNS myelin in the absence of proteolipid protein. Neuron. 18: 59-70. PMID 9010205 DOI: 10.1016/S0896-6273(01)80046-5  0.583
Show low-probability matches.